Cargando…
Virtual Screening and Prediction of Binding of Caprine CSN1S2 Protein Tryptic Peptides to Glucokinase
INTRODUCTION: Glucokinase (hexokinase D) is an enzyme that phosphorylates glucose in hepatocytes totrap it in the cell and prime it for conversion to other compounds, yet this enzyme has low affinity to bind with glucose. In Diabetes Mellituspatients, the blood glucose level is poorly controled. MAT...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723197/ https://www.ncbi.nlm.nih.gov/pubmed/29284910 http://dx.doi.org/10.5455/aim.2017.25.225-231 |
_version_ | 1783285169007886336 |
---|---|
author | Fatchiyah, Fatchiyah Rahasta, Atika Hanoum Cairns, James R. Ketudat |
author_facet | Fatchiyah, Fatchiyah Rahasta, Atika Hanoum Cairns, James R. Ketudat |
author_sort | Fatchiyah, Fatchiyah |
collection | PubMed |
description | INTRODUCTION: Glucokinase (hexokinase D) is an enzyme that phosphorylates glucose in hepatocytes totrap it in the cell and prime it for conversion to other compounds, yet this enzyme has low affinity to bind with glucose. In Diabetes Mellituspatients, the blood glucose level is poorly controled. MATERIAL AND METHODS: This study explored the possibility to induce glucokinase activity with bioactive peptides derived from the goat milk protein CSN1S2 by in- silico docking approach. Two bioactive tryptic peptides, CSN1S2 residues 41-47 and 214-221, were successfully docked to glucokinase and found to bind to the activation site. RESULTS: Amino acid residues Asn41, Ala43, His45 and Arg221 from these peptides provided the major contribution to docking to glucokinase. Asn41 made more interactions with glucokinase than the other residues in the peptide, including hydrogen bonds and salt-bridge These bioactive peptides appear to help glucokinase to bind glucose, since the number of hydrogen bonds between the protein and the glucose was higher and their distances shorter in the complex with the peptides without disturbing the glucose position for phosphorylation. CONCLUSION: Thus, the activation effect of the CSN1S2 derived bioactive peptides for glucokinase binding affinity of glucose is indicated by this study. |
format | Online Article Text |
id | pubmed-5723197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | AVICENA, d.o.o., Sarajevo |
record_format | MEDLINE/PubMed |
spelling | pubmed-57231972017-12-28 Virtual Screening and Prediction of Binding of Caprine CSN1S2 Protein Tryptic Peptides to Glucokinase Fatchiyah, Fatchiyah Rahasta, Atika Hanoum Cairns, James R. Ketudat Acta Inform Med Original Paper INTRODUCTION: Glucokinase (hexokinase D) is an enzyme that phosphorylates glucose in hepatocytes totrap it in the cell and prime it for conversion to other compounds, yet this enzyme has low affinity to bind with glucose. In Diabetes Mellituspatients, the blood glucose level is poorly controled. MATERIAL AND METHODS: This study explored the possibility to induce glucokinase activity with bioactive peptides derived from the goat milk protein CSN1S2 by in- silico docking approach. Two bioactive tryptic peptides, CSN1S2 residues 41-47 and 214-221, were successfully docked to glucokinase and found to bind to the activation site. RESULTS: Amino acid residues Asn41, Ala43, His45 and Arg221 from these peptides provided the major contribution to docking to glucokinase. Asn41 made more interactions with glucokinase than the other residues in the peptide, including hydrogen bonds and salt-bridge These bioactive peptides appear to help glucokinase to bind glucose, since the number of hydrogen bonds between the protein and the glucose was higher and their distances shorter in the complex with the peptides without disturbing the glucose position for phosphorylation. CONCLUSION: Thus, the activation effect of the CSN1S2 derived bioactive peptides for glucokinase binding affinity of glucose is indicated by this study. AVICENA, d.o.o., Sarajevo 2017-12 /pmc/articles/PMC5723197/ /pubmed/29284910 http://dx.doi.org/10.5455/aim.2017.25.225-231 Text en Copyright: © 2017 Fatchiyah Fatchiyah, Atika Hanoum Rahasta, James R. Ketudat Cairns http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Paper Fatchiyah, Fatchiyah Rahasta, Atika Hanoum Cairns, James R. Ketudat Virtual Screening and Prediction of Binding of Caprine CSN1S2 Protein Tryptic Peptides to Glucokinase |
title | Virtual Screening and Prediction of Binding of Caprine CSN1S2 Protein Tryptic Peptides to Glucokinase |
title_full | Virtual Screening and Prediction of Binding of Caprine CSN1S2 Protein Tryptic Peptides to Glucokinase |
title_fullStr | Virtual Screening and Prediction of Binding of Caprine CSN1S2 Protein Tryptic Peptides to Glucokinase |
title_full_unstemmed | Virtual Screening and Prediction of Binding of Caprine CSN1S2 Protein Tryptic Peptides to Glucokinase |
title_short | Virtual Screening and Prediction of Binding of Caprine CSN1S2 Protein Tryptic Peptides to Glucokinase |
title_sort | virtual screening and prediction of binding of caprine csn1s2 protein tryptic peptides to glucokinase |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723197/ https://www.ncbi.nlm.nih.gov/pubmed/29284910 http://dx.doi.org/10.5455/aim.2017.25.225-231 |
work_keys_str_mv | AT fatchiyahfatchiyah virtualscreeningandpredictionofbindingofcaprinecsn1s2proteintrypticpeptidestoglucokinase AT rahastaatikahanoum virtualscreeningandpredictionofbindingofcaprinecsn1s2proteintrypticpeptidestoglucokinase AT cairnsjamesrketudat virtualscreeningandpredictionofbindingofcaprinecsn1s2proteintrypticpeptidestoglucokinase |